On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Betagenon AB's own share of each project, not the project's full budget.
- Horizon 2020€1.8M · 1 project
Projects
1 EU-funded project, newest first. Betagenon AB led 1 of them as coordinator. Each links to the official record.
- AMPK-DIABCoordinator
A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novel innovative drug for the treatment of type 2 diabetes
Horizon 2020 · 2016–2018 · Project on CORDIS ↗
€1.8Mtheir share
Fields it works in
Research fields recorded on its Horizon projects.
- cardiovascular diseases
- diabetes
- obesity
- peripheral vascular disease
- vascular diseases
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.